Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-18-001053)

Filing Details

Accession Number:: 0001225208-18-001053
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-01-16 17:13:01
Reporting Period:: 2018-01-16

Accepted Time:: 2018-01-16 17:13:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1390613	J Michael Holston	Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-01-16	12,500	$61.63	49,092	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
Holdings include shares acquired in dividend reinvestment transactions.